China Cosmetic Regulatory Updates | New Cosmetics Ingredients (NCI) Notification in China In September 2024, 6 new cosmetic ingredients were filed with the China National Medical Products Administration (NMPA). They include: Notification No. Ingredient Name in CN & EN Notifier in CN 20240065 吡咯并喹啉醌二钠盐 (Pyrroloquinoline Quinone Disodium Salt) 润辉生物技术 20240066 3,4-二羟基苯乙醇 (Hydroxytyrosol) 上海华茂药业 20240067 金露梅（DASIPHORA FRUTICOSA）提取物 (Dasiphora Fruticosa Extract) 贝泰妮 20240068 β-烟酰胺单核苷酸 (Nicotinamide Mononucleotide) 邦泰生物 20240069 L-高丝氨酸 (L-Homoserine) 盛德百泰生物 20240070 麦芽糖酸 (Maltobionic Acid) 上海克琴 The technical requirements for the 6 NCI mentioned above have not been disclosed, and they have not yet entered the monitoring period. In
